Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Open | $0.234 |
Close | - |
Volume / Avg. | 165.525K / 1.050M |
Day Range | 0.230 - 0.240 |
52 Wk Range | 0.144 - 5.000 |
Market Cap | $11.496M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 43 |
Short Interest | 0.12% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calidi Biotherapeutics (AMEX: CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Dominari Holdings (NASDAQ:DOMH) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for Calidi Biotherapeutics (AMEX: CLDI) was reported by Baird on Wednesday, May 15, 2024. The analyst firm set a price target for 2.00 expecting CLDI to rise to within 12 months (a possible 751.79% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $0.2348 last updated Today at May 16, 2024 at 12:50 PM EDT.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.